Seven Eight Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Seven Eight Capital’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-66,874	Closed	-$7.62M	–	801
2019 Q1	$7.62M	Buy	+66,874	New	+$4.92M	0.4%	65
2017 Q4	–	Sell	-13,900	Closed	-$1.24M	–	625
2017 Q3	$1.24M	Buy	+13,900	New	+$1.06M	0.15%	213
2016 Q3	–	Sell	-934	Closed	-$48K	–	613
2016 Q2	$48K	Buy	+934	New	+$39.9K	0.02%	455

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Seven Eight Capital's ONCE Position: Q2 2019 in Review

Seven Eight Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 66,874 shares — an estimated $7.62M sold.

Seven Eight Capital first reported a position in ONCE in Q2 2016 and held it in 3 quarters. The position peaked at $7.62M in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

Seven Eight Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Seven Eight Capital sold 66,874 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $7.62M.
Seven Eight Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
Seven Eight Capital's Spark Therapeutics, Inc. Common Stock position peaked at $7.62M in Q1 2019.
194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Seven Eight Capital's 13F filing for Q2 2019, filed 12 Aug 2019.